Fundraising Fox

Ivenix

Amesbury, US · Delaware corporation · 4 known investors

ivenix.com ↗

Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors. The system is designed for nursing staff, pharmacists, IT departments, clinical engineers, and anesthesia professionals in healthcare facilities.

BiotechHealthtechMedical Devicesin /fresenius-kabi-usa

Founders & leadership

JM
John M. DouglassDirector
JS
John SokolowskiExecutive Officer
JK
John K. ClarkeDirector
JA
Jesse AmbrosinaExecutive Officer
CJ
Colin J. FosterDirector
DJ
Darrell J. CrateDirector
GW
George W. GrayExecutive Officer
CM
Carolyn MalleckExecutive Officer
KP
Ketan PatelDirector
WB
Wayne B. WeismanDirector

Investors · 4

Cardinal PartnersPrinceton
SCP Vitalife PartnersTel Aviv · $3M – $7Mvia Wayne B. Weisman · board
ECO Fleet HoldingsreportedBeverly
F-Prime Capital PartnersreportedCambridge · $3M – $10M

Reported raises · per SEC filings

Form D private placements
▶$10MraisedMar 2017 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • George GrayExecutive Officer
  • John ClarkeDirector
  • John DouglassDirector
  • Stuart RandleExecutive Officer, Director
  • John WuDirector
  • Jesse AmbrosinaExecutive Officer
  • Ketan PatelDirector
  • Wei LiDirector
Offering amount
$50M
Amount sold
$10M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$27.5MraisedSep 2015 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John SokolowskiExecutive Officer
  • Darrell CrateDirector
  • George GrayExecutive Officer
  • John DouglassDirector
  • Carolyn MalleckExecutive Officer
  • Jesse AmbrosinaExecutive Officer
Offering amount
$27.5M
Amount sold
$27.5M
Sales commissions
$756.1K
Placement agents
Leerink Partners LLC
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.8MraisedSep 2015 · 43 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ketan PatelDirector
  • John M. DouglassDirector
  • John SokolowskiExecutive Officer
  • John K. ClarkeDirector
  • Jesse AmbrosinaExecutive Officer
  • Colin J. FosterDirector
  • Wayne B. WeismanDirector
  • Darrell J. CrateDirector
  • George W. GrayExecutive Officer
  • Carolyn MalleckExecutive Officer
Offering amount
$14.8M
Amount sold
$14.8M
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news